Roivant Sciences Ltd (ROIV) support and resistance · rev $8.3M
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
This page maps Roivant Sciences Ltd (ROIV) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ROIV revenue for 2026-03-31 was $8.3M. Net income was -$299.8M. Revenue was down 71.6% from 2025-03-31 to 2026-03-31. ROIV currently screens at market cap $7.47B.
ROIV currently screens at market cap $7.47B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ROIV 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ROIV quote page for the session range and the stock page for the full model.
Not investment advice.